Try our Advanced Search for more refined results

J&J Settlement Ends Latest Pa. Risperdal Case Before Trial

By Matt Fair (November 2, 2016, 4:32 PM EDT) -- Johnson & Johnson agreed to an undisclosed settlement in order to avoid a trial that was slated to begin in Pennsylvania state court on Monday in the latest case over abnormal breast growth that adolescent boys claim they have suffered after taking the antipsychotic drug Risperdal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!